Indena S.p.A.
Indena S.p.A., founded in 1921 and headquartered in Milan, develops and manufactures plant-derived active pharmaceutical ingredients, botanical extracts, and Phytosome®-enhanced nutraceutical ingredients, selling B2B to global pharmaceutical, nutraceutical, cosmetic, and food companies alongside emerging CDMO services for HPAPIs, PDCs, and ADCs.
- Company typePrivate
- Founded1921
- HeadquartersMilano, Italy
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Indena S.p.A. does
Indena S.p.A. is a privately held, Milan-headquartered Italian company founded in 1921 and part of the IdB Holding group, specializing in the identification, development, and production of plant-derived active pharmaceutical ingredients, semi-synthetic APIs, and standardized botanical extracts. Its technical platform is anchored by the proprietary Indena Phytosome® delivery system — a food-grade lecithin-based solid dispersion technology with over 7 billion servings delivered globally, backed by approximately 100 patents and 100+ human clinical studies. Manufacturing capabilities extend to high-potency APIs with occupational exposure limits down to 1 ng/m³, peptide drug conjugate and antibody-drug conjugate production, GEA PSD2 spray drying, and 1,000–20,000 L multipurpose fermentation, with cGMP-certified sites in Settala and Palestro (Italy), Tours (France), and India, plus raw-material sourcing across 100+ plant species in 30+ countries. Differentiated traceability is delivered through DNA barcoding, an exclusive field-testing arrangement using Hyeshift's bCUBE® devices, and the proprietary IN-DNA certification mark.
The company sells primarily B2B into four end-markets: pharmaceutical companies (oncology APIs such as paclitaxel, docetaxel, cabazitaxel, and other semi-synthetic taxanes; central nervous system, cardiovascular, and anti-inflammatory APIs), nutraceutical and functional-food brands (branded Phytosome®-enabled ingredients including Quercefit®, Ubiqsome®, Meriva®, Mirtoselect®, Berbevis®, Centextra®, and 20+ other SKUs), cosmetics and personal care, and food & beverage. Distribution is direct enterprise sales through regional business representatives, supported by dedicated websites for the USA, Japan, and China, plus industry trade shows (CPHI, Vitafoods, DCAT, SupplySide). A growing third revenue stream is Contract Development and Manufacturing Organization services, including recent strategic alliances with Chemi S.p.A./Italfarmaco Group for peptide drug conjugates, TCG GreenChem for next-generation ADCs, Givaudan for beauty/wellness extracts, and Onegevity for AI-assisted indication discovery. Pricing is negotiated per inquiry and not publicly disclosed, and revenue figures are not reported. Headcount is in the 501–1,000 range, with 28% of staff in Quality and R&D, 95% on permanent contracts, and average tenure of 17 years.
Indena S.p.A. firmographics
Firmographics- Name
- Indena S.p.A.
- Legal name
- Indena S.p.A.
- Website
- https://indena.com
- Company type
- Private
- Founded year
- 1921
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Indena S.p.A., founded in 1921 and headquartered in Milan, develops and manufactures plant-derived active pharmaceutical ingredients, botanical extracts, and Phytosome®-enhanced nutraceutical ingredients, selling B2B to global pharmaceutical, nutraceutical, cosmetic, and food companies alongside emerging CDMO services for HPAPIs, PDCs, and ADCs.
- Ownership category
- akta.pro rank
Indena S.p.A. industry classification
Industry- Product category
- Botanical Pharmaceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)
- akta.pro secondary industries
- Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol) (AFAJAKAI), Herbal & Botanical Supplements (CRADAGAD)
Keywords
Where Indena S.p.A. is headquartered
LocationHeadquarters
- HQ city
- Milano
- HQ country
- Italy
- HQ region
- Europe
Offices8 records
Markets served
Indena S.p.A. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Botanical Pharmaceutical Ingredients (APIs): Sale of plant-derived and semi-synthetic active pharmaceutical ingredients to pharmaceutical companies for use in finished drug products. Includes oncology drugs (paclitaxel, docetaxel), cardiovascular, neurological, and anti-inflammatory compounds.
- Nutraceutical Ingredients: Sale of standardized botanical extracts and proprietary Phytosome®-formulated ingredients to nutraceutical, functional food, cosmetic, and personal care companies.
- CDMO (Contract Development and Manufacturing) Services: Fee-for-service contract manufacturing and development services for biotech and pharmaceutical clients requiring complex API manufacturing, HPAPI production, and targeted therapeutic development (ADCs, PDCs).
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Indena S.p.A. product offering
Product offeringCore offering
Indena S.p.A. identifies, develops, and produces plant-derived active pharmaceutical ingredients (APIs), standardized botanical extracts, and proprietary Phytosome®-formulated nutraceutical ingredients. The company also offers CDMO services for complex APIs, high-potency molecules (HPAPIs), and targeted therapeutics including peptide drug conjugates (PDCs) and antibody-drug conjugates (ADCs). Its portfolio spans oncology, cardiovascular, neurological, anti-inflammatory, and metabolic health APIs, alongside branded nutraceutical ingredients serving the supplement, functional food, and personal care industries.
Product overview
Indena S.p.A. is a Milan-based pharmaceutical and nutraceutical ingredient company founded in 1921, offering a comprehensive portfolio of botanical derivatives and CDMO services. The company's product portfolio includes over 100 pharmaceutical active ingredients (APIs) and nutraceutical products, organized into three main categories: (1) Proprietary Indena Phytosome® Technology Platform - a delivery system that improves bioabsorption of phytonutrients using food-grade lecithin matrices, with over 7 billion servings delivered globally; (2) Nutraceuticals - branded ingredients including Quercefit®, Ubiqsome®, Centextra®, Meriva®, Berbevis®, Mirtoselect®, and many others targeting health areas such as healthy aging, brain health, beauty from within, chronic ache relief, and weight management; (3) Pharmaceuticals - APIs including Paclitaxel, Docetaxel, Cabazitaxel, Voclosporin, and other botanical and semi-synthetic compounds for oncology, cardiovascular, and neurological applications. The company also provides CDMO services for complex APIs and targeted therapeutics including peptide drug conjugates.
Differentiator
Problem solved
Functional benefit
Brands
- Indena Phytosome®: Proprietary technology platform that creates solid dispersions of phytonutrients within a food-grade lecithin matrix to improve bioabsorption of natural compounds
- Quercefit®
- Ubiqsome®
- Purebkale®
- Meriva®
- Mirtoselect®
- Centextra®
- Enovita®
- Casperome®
- Anthocran®
- Siliphos®
- Cronilief™
- Mitidol®
- Relissa™
- Berbevis®
- Vazguard®
- Ginkgoselect® Plus
- Leucoselect®
- Greenselect®
- Sabalselect®
- Opextan®
- Virtiva® Plus
- Prodigest®
- CUBO™
- Beanblock®
- Alextan®
- Cinaran®
- Bilear®
- Lactolycopene
- Polinacea®
- Immunoselect®
- Centevita®
Products and services
- Indena Phytosome® Technology Platform Proprietary delivery technology platform creating solid dispersions of phytonutrients within a food-grade lecithin matrix, significantly improving bioabsorption, enhancing gut microbiome interaction, and providing exceptional stability and safety for nutraceutical applications.
- CDMO Services for Complex APIs and Targeted Therapeutics Contract Development and Manufacturing Organization services providing integrated peptide drug conjugate (PDC) manufacturing, HPAPI production, and conjugation capabilities for biotech and pharmaceutical clients developing targeted therapeutics.
- Centextra® Innovative skin health solution combining Centella asiatica triterpenes with Indena Phytosome® technology, designed to reduce oxidative stress, rebalance inflammatory response, promote wound healing, and restore collagen levels.
- Berbevis® Berberine extract ingredient powered by Indena Phytosome® technology, supporting metabolic health and optimizing blood sugar and lipid profiles.
- Quercefit® Smart Indena Phytosome® quercetin formulation derived from Sophora japonica L. that helps slow down cellular aging through senolytic activity, backed by over 10 human studies.
- Ubiqsome® First CoQ10-based health-food ingredient formulated with Indena Phytosome® technology, with scientifically proven enhanced absorption and delivery into muscles, cells, and mitochondria supporting cellular energy production.
- Meriva® Curcumin ingredient formulated with Indena Phytosome® technology to optimize bioabsorption, backed by over 40 human studies supporting healthy inflammatory response in aging bodies.
- Mirtoselect® Bilberry extract from wild Vaccinium myrtillus with proprietary anthocyanin profile for antioxidant activity and neurological protection.
- Enovita® Organic Scientifically validated 100% organic grape seed extract rich in oligomeric proanthocyanidins, clinically proven to help maintain blood pressure within normal range and support cardiovascular wellbeing.
- Siliphos® Silybin from Silybum marianum formulated with Indena Phytosome® technology for liver health and antioxidant protection.
- Paclitaxel Natural taxane-derived anticancer agent from Taxus baccata L. used in cancer chemotherapy, supplied as an active pharmaceutical ingredient to global pharmaceutical companies.
- Docetaxel Semi-synthetic taxane anticancer agent derived from 10-deacetylbaccatin III used in cancer treatment, supplied as an active pharmaceutical ingredient.
- Colchicine Antigout active pharmaceutical ingredient for treatment of gout and familial Mediterranean fever.
- Cannabidiol (CBD) Pharmaceutical grade cannabinoid active pharmaceutical ingredient derived from Cannabis sativa L. for various therapeutic applications; first globally to secure European CEP certification.
Quantifiable outcome
- Over 7 billion servings of Phytosome® products delivered globally
- +3 more outcomes
Companies that use Indena S.p.A.
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Indena S.p.A. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Indena S.p.A. partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Chemi S.p.A. / Italfarmaco GroupcorePartnership to provide integrated peptide drug conjugate (PDC) manufacturing services, combining Chemi's peptide synthesis expertise with Indena's high-potency molecule and conjugation capabilities. Positions both companies as strategic development and manufacturing partners for biotech and pharmaceutical clients in the rapidly evolving targeted therapeutics field.
- Onegevity Health IntelligencecoreCollaboration to develop innovative approaches for preventative health using Onegevity's AI platform to analyze botanical ingredients from Indena's portfolio to discover novel potential indications and beneficial effects for pharmaceutical and nutraceutical applications. Aims to identify strategies to reduce biological age versus chronological age and provide actionable personalized health solutions globally.
- TCG GreenChemcoreStrategic alliance to advance next-generation ADC (antibody-drug conjugate) technologies, combining Indena's HPAPI manufacturing and conjugation capabilities with TCG GreenChem's green chemistry expertise.
- GivaudanminorPartnership to advance plant-based extracts for the beauty and wellness sector, combining Givaudan's flavor and fragrance capabilities with Indena's botanical expertise.
- Alvinesa Natural IngredientsminorCollaboration to develop Enovita® Organic, a 100% organic grape seed extract combining Indena's botanical expertise with Alvinesa's natural antioxidant capabilities, delivering quality and sustainability in stress resilience ingredients.
Scale indicators13 records
Recent moves6 records
Expansion highlights7 records
Indena S.p.A. competitors and assessment
Company assessmentDirect peers
- Sabinsa (Sami-Sabinsa Group): Sabinsa is a privately held manufacturer of standardized botanical extracts and nutraceutical ingredients with a comparable branded-ingredient portfolio, similar science-led positioning, and overlapping pharma and supplement end-markets. Both companies compete head-to-head in categories like curcumin, boswellia, and berberine extracts.
- Euromed (Euromed S.A.): Euromed produces standardized botanical extracts and natural APIs for the pharmaceutical and nutraceutical industries with cGMP manufacturing and clinical evidence backing. Its product portfolio (saw palmetto, milk thistle, tomato, cranberry) overlaps directly with Indena's branded nutraceutical range.
- PLT Health Solutions: PLT Health Solutions is a US-based developer of branded, science-backed botanical and nutritional ingredients marketed to supplement brands, directly comparable to Indena's branded Phytosome® ingredient business. Both emphasize clinical validation, IP-protected ingredients, and B2B sales to nutraceutical formulators.
- Naturex (Givaudan): Naturex (acquired by Givaudan) produces natural specialty ingredients including botanical extracts and phytoactives across nutraceutical, food, and personal-care markets. It historically competes with Indena in standardized botanical ingredients, though now owned by one of Indena's named partners.
Broad incumbents
- Givaudan: Through its Active Beauty and Taste & Wellbeing divisions, plus the Naturex acquisition, Givaudan is a global flavor, fragrance, and botanical ingredient incumbent that competes across many of Indena's nutraceutical and beauty-from-within categories. Givaudan is a current Indena partner (plant-based extracts for beauty), giving it both direct overlap and strategic familiarity.
- DSM-Firmenich: DSM-Firmenich is a diversified nutrition, health, and ingredients conglomerate with an extensive botanical and nutraceutical portfolio, vitamin premixes, and CDMO-adjacent services. It competes with Indena across vitamins, carotenoids, polyphenol-based ingredients, and increasingly in CDMO/biotech-adjacent categories.
- Kemin Industries: Kemin Industries is a diversified ingredient manufacturer with botanical, functional food, and personal-care product lines, including antioxidant, preservative, and specialty extract offerings that overlap with Indena's antioxidant and nutraceutical ingredients. Kemin's vertically integrated supply chain serves similar B2B channels.
- Catalent: Catalent is a major global CDMO providing development and manufacturing for biologics, oral and injectable dose forms, and cell/gene therapies. It is comparable to Indena's CDMO expansion into HPAPI and peptide drug conjugates from the CDMO services perspective, even though Catalent operates at meaningfully larger scale.
Emerging players
- Botanic Healthcare: Botanic Healthcare is an India-based manufacturer of standardized herbal extracts, phytopharmaceuticals, and nutraceutical ingredients with GMP-certified facilities. It is a comparable botanical-ingredient producer serving similar nutraceutical and supplement customers globally, especially in cost-sensitive segments.
- Chemi S.p.A. (Italfarmaco Group): Chemi S.p.A., part of Italfarmaco Group, is an Italian CDMO with expertise in peptide synthesis and is Indena's explicit partner for the integrated PDC manufacturing offering. As a partner-collaborator with overlapping customer bases in targeted therapeutics, Chemi is a directly comparable emerging CDMO in the peptide/HPAPI space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
Indena S.p.A. social profiles
Digital presenceIndena S.p.A. compliance and trust
Trust signalCompliance13 records
Indena S.p.A. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Indena S.p.A. leadership team
Management profileNumber of profiles
Profiles5 records
Indena S.p.A. subsidiaries and ownership
Company hierarchySubsidiaries1 record
Indena S.p.A. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Indena S.p.A. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Indena S.p.A.
What does Indena S.p.A. do?
Indena S.p.A. identifies, develops, and produces plant-derived active pharmaceutical ingredients (APIs), standardized botanical extracts, and proprietary Phytosome®-formulated nutraceutical ingredients. The company also offers CDMO services for complex APIs, high-potency molecules (HPAPIs), and targeted therapeutics including peptide drug conjugates (PDCs) and antibody-drug conjugates (ADCs). Its portfolio spans oncology, cardiovascular, neurological, anti-inflammatory, and metabolic health APIs, alongside branded nutraceutical ingredients serving the supplement, functional food, and personal care industries.
Is Indena S.p.A. a public or private company?
Indena S.p.A. is a private company. It is classified as family owned and is currently operating.
When was Indena S.p.A. founded?
Indena S.p.A. was founded in 1921. It employs 501 to 1,000 people.
Where is Indena S.p.A. based?
Indena S.p.A. is headquartered in Milano, Italy, in the Europe region.
How does Indena S.p.A. make money?
Three revenue lines are on record. Botanical Pharmaceutical Ingredients (APIs) is the primary driver. The others are nutraceutical Ingredients and CDMO (Contract Development and Manufacturing) Services.
Who are Indena S.p.A.'s main competitors?
Direct peers on record are Sabinsa (Sami-Sabinsa Group), Euromed (Euromed S.A.), PLT Health Solutions and Naturex (Givaudan). Broad incumbents are Givaudan, DSM-Firmenich, Kemin Industries and Catalent. Emerging players are Botanic Healthcare and Chemi S.p.A. (Italfarmaco Group).
Does Indena S.p.A. have an API?
No public API is recorded for Indena S.p.A..
What industry is Indena S.p.A. in?
Indena S.p.A.'s product category is Botanical Pharmaceutical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives. Its NAICS code is 325411 and its SIC code is 2833.